Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
2021 SNEC丨Arctech Signed MoU 1GW Solar Tracker Delivery Worldwide 2021-06-08 11:01
CGTN launches 'Media Challengers' theme song 2021-06-08 09:58
CGTN: Peng Liyuan calls for global efforts in AIDS and TB prevention and treatment 2021-06-08 09:37
PingPong Payments launches new PLN and SEK currency exchange services 2021-06-08 09:00
Innovent Biologics and IASO Biotherapeutics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress 2021-06-08 08:00
Mech-Mind Announces New-Gen Mech-Eye Pro Enhanced Industrial 3D Camera to Enable Smarter Robotics of Industry 4.0 2021-06-08 08:00
Live from ASCO 2021 | Ascentage Pharma Delivers Oral Presentation Featuring Updated Data Demonstrating Promising Efficacy and Safety of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Patients with Relapsed or Refractory CLL/SLL 2021-06-08 07:30
Live from ASCO 2021 | Ascentage Pharma Presents Updated Results of MDM2-p53 Inhibitor Alrizomadlin (APG-115) Demonstrating an ORR of 24.1% Including Complete Response in Combination with Pembrolizumab in Patients with Advanced Melanoma Resistant or Refractory to Prior Immuno-Oncologic Drugs 2021-06-08 07:21
India's largest bank SBI invests in leading digital payments firm Cashfree 2021-06-07 23:29
Second Global Health Forum of Boao Forum for Asia: A Call for Innovation and Collaboration to Promote the Progress of the Global Health System 2021-06-07 21:35
vivo officially launches VISION+ Mobile PhotoAwards 2021 2021-06-07 21:00
KYMCO Announces Ionex EV League 2021-06-07 20:07
Nium Signs Definitive Agreement to Acquire B2B Travel Payments Leader Ixaris 2021-06-07 17:00
China makes great efforts to contain COVID-19, saves more lives: SCO Secretary-General 2021-06-07 11:35
Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Plus Paclitaxel/Cisplatin for the First-line Treatment of ESCC at ASCO 2021 2021-06-07 10:11
Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Combined with Chemotherapy for the Treatment of Advanced NSCLC at ASCO 2021 2021-06-07 10:10
OriginCell Therapeutics Presents Positive Results of GPC3 CAR-T in HCC Trial at the 2021 ASCO Annual Meeting 2021-06-07 10:00
Hyperice Named Official Recovery Technology Partner by League of Legends Pro League 2021-06-07 10:00
Poster Highlighting Clinical Data of KN046 Plus Nab-Paclitaxel/Gemcitabine as First-Line Treatment for Pancreatic Cancer Is Presented at ASCO 2021 2021-06-07 09:53
CSOP Asset Management Ltd. Chooses SS&C to Support Operations 2021-06-07 09:00
1 528 529 530 531 532 1162